Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dimethyl fumarate for palmoplantar pustulosis (24-week open-label phase II trial)
2017-003386-10Phase 2Terminated
- Sponsor
- Medical University of Vienna
- Start
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of dimethyl fumarate in Palmoplantar Pustular Psoriasis (PPPP), sponsored by Medical University of Vienna. Primary endpoint: ppPASI-75 response. Started Nov 2017; status: terminated.
02
Drugs
dimethyl fumarate
03
Conditions
Palmoplantar Pustular Psoriasis (PPPP)
Beyond the preview
Go deeper on 2017-003386-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-003386-10.